Navigation Links
Arobella Medical, LLC Launches Qoustic Wound Therapy System(TM)

Product focuses ultrasound debridement to gently clean and help heal

chronic wounds

MINNEAPOLIS, Feb. 11 /PRNewswire/ -- Arobella Medical, LLC, today announced that it has launched the Qoustic Wound Therapy System(TM), which advances the use of low-frequency cavitational ultrasound for wound care. The product offers a safe, cost-effective alternative to painful sharps debridement and other surgical modalities. The Qoustic Wound Therapy System assists healing by gently removing dead or diseased tissue cells and bacteria, leaving healthy and pre-healing granulation tissue intact. It is also useful in preparing the wound bed for other therapies, such as grafts and flaps.

Low-frequency ultrasound debridement is emerging as a preferred method of care for many types of wounds, including pressure ulcers, diabetic ulcers, infected wounds, burns and other chronic wounds. Five to seven million people each year in the United States require treatment for chronic wounds resulting from ulcers, sores, burns, fistulas and other conditions. A significant number of the people with chronic wounds have diabetes, and rapid growth of the diabetic population is increasing the need for advanced wound care.

"The Qoustic Wound Therapy System debrides by deploying focused ultrasound energy directly on the wound bed, notably improving the effectiveness of debridement versus sharps debridement alone. The use of ultrasound helps preserve healthy tissue and protects newly formed granulation tissue, while being gentle and efficient," said Eliaz Babaev, PhD, president and CEO of Arobella Medical. "The system has the potential to significantly advance patient care and health care worker safety, as well as reduce costs."

The Qoustic Wound Therapy System removes harmful bacteria and biofilm and improves wound bed circulation. The system's unique, dome-shaped Qoustic Qurette(TM) vibrates at 35 kHz, converting electrical energy to ultrasound waves and focusing them intensively on the wound. Sterile saline solution transfers the ultrasonic energy to the wound, where tiny vibrating gas bubbles and cellular-level fluid movement separate dead and harmful cells from healthy tissue. As a result, dead and harmful cells are fragmented and destroyed, thus aiding in their easy removal with the edge of the Qoustic Qurette.

The Qoustic Wound Therapy System is portable and can be used in many health care settings - including the bedside - by certified wound care specialists, including physicians, registered nurses, nurse practitioners, physician assistants, physical therapists and podiatrists. The system reduces splash and aerosolization. It can reduce wound care costs in several ways: fast setup, no required disposables, short procedure times, effective procedures that reduce debridement frequency, efficient use of saline and fast cleanup. The system has FDA 510(k) clearance and uses established reimbursement codes for selective and non-selective surgical debridement and active wound care management.

"Of the ultrasonic wound care devices on the market, I am most impressed by the Qoustic Wound Therapy System, particularly its ease of use and controlled debridement of wounds," said Dr. Jeffrey A. Niezgoda, MD, medical director of Hyperbaric and Wound Care Associates in Milwaukee. "The system allows me to remove diseased tissue while protecting healthy tissue."

Benefits of Ultrasound for Wound Care

When electrical energy is converted to mechanical motion, sound pressure waves are created. These ultrasound waves can have thermal and/or physical effects in tissue. Low-frequency ultrasound has been shown to have cellular- level physical effects, known as cavitation and microstreaming, that can promote healing. Cavitation is the formation and oscillation of microscopic bubbles, which expand and collapse as they resonate with the ultrasound frequency. Acoustic microstreaming is the physical force of sound pressure waves that can displace small molecules and move fluids along and/or through cell membranes. Together, these effects alter cellular activity and protein synthesis, both of which are critical in repairing tissue damage. Scientific studies have demonstrated that ultrasound debridement is a convenient and effective wound care technique.

About Arobella Medical, LLC

Arobella Medical, LLC is Minneapolis-based medical device company specializing in low-frequency ultrasound for wound care and other wound management therapies. Arobella Medical, LLC is positioned to become a leader in advanced ultrasound wound care technologies and devices. Arobella Medical, LLC co-founder and CEO Eliaz Babaev has more than 45 years of experience developing, designing and commercializing medical devices that use ultrasound. For more information, go to

SOURCE Arobella Medical, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Tutogen Medical, Inc. Reports First Quarter Fiscal 2008 Financial Results
2. Nonin Medical, Inc. Receives Frost & Sullivans 2007 Award for Product Differentiation Innovation
3. Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results
4. Tutogen Medical, Inc. to Report Fourth Quarter and Fiscal Year 2007 Financial Results
5. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
6. Tutogen Medical, Inc. to Present at the Roth Capital Partners 2007 New York Conference
7. Barr Launches Generic Fosamax(R) Tablets, 70 mg
8. NHS Choices Launches New BMI Calculator
9. Oncothyreon launches new corporate website
10. Blue Cross and Blue Shield of Texas Launches an Integrated Medical-Dental Health Program
11. Arryx Launches HOTkit(TM) Complete for Dynamic, Scientific Manipulation of Microscopic Elements
Post Your Comments:
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Researchers at ... most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the ... read it now. , Diagnostic biomarkers are signposts in the blood, lung fluid ...
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, one of the ... brand, UP4™ Probiotics, into Target stores nationwide. The company, which has been manufacturing ... to its list of well-respected retailers. This list includes such fine stores as ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:5/12/2016)... , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
Breaking Biology News(10 mins):